查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1765149

全球灌注系統市場

Perfusion Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球灌注系統市場規模將達到 16 億美元

全球灌注系統市場規模預計在2024年為12億美元，到2030年將達到16億美元，在2024-2030年的分析期間內，複合年成長率為4.4%。心肺灌注系統是本報告分析的細分市場之一，預計其複合年成長率為3.4%，到分析期結束時規模將達到6.71億美元。細胞灌注系統細分市場在分析期間內的複合年成長率預計為4.1%。

美國市場規模估計為 3.36 億美元，中國市場預計複合年成長率為 4.1%

美國灌注系統市場規模預計2024年達到3.36億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到2.549億美元，在2024-2030年的分析期間內，複合年成長率為4.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.0%和3.6%。在歐洲，預計德國市場的複合年成長率為4.5%。

全球灌注系統市場－主要趨勢與促進因素摘要

灌注系統將如何徹底改變醫療程序？

灌注系統在現代醫療程序中發揮著至關重要的作用，它在手術和其他關鍵醫療干預期間有效地向組織和器官輸送氧氣和必需營養素。這些系統在心肺體外迴圈手術、器官移植和各種加護治療中至關重要。例如，在開胸心臟外科手術期間，灌注系統暫時接管心臟和肺部的功能，維持血液循環和氧氣供應。此功能對於複雜外科手術的成功至關重要，並顯著改善了患者的預後。此外，在器官移植中，灌注系統用於保存體外器官，延長移植時間並提高捐贈器官的存活率。灌注系統的精確性和可靠性徹底改變了外科手術和重症加護領域，使得更複雜和挽救生命的手術能夠安全地進行。

哪些技術創新正在塑造灌注系統？

技術創新是灌注系統進步的前沿，提高了系統的效率、安全性和功能性。一個顯著的發展是先進監測和控制技術的整合，可以即時評估和調整灌注參數。這確保了最佳灌注條件並降低了併發症的風險。另一項關鍵創新是在灌注設備的構造中使用生物相容性材料和塗層，最大限度地降低了副作用的風險並提高了患者的安全性。此外，可攜式微創灌注系統的出現已將其應用範圍從手術室擴展到了野戰醫院和急救環境。軟體和數據分析的進步也使得更精確的控制和監測成為可能，從而改善了手術和非手術程序的結果。這些技術進步使灌注系統更加通用和有效，滿足了醫療保健專業人員不斷變化的需求。

灌注系統在不同的醫學學科中是如何應用的？

灌注系統廣泛應用於各個醫學學科，每個學科都有其獨特的功能來改善病患照護。在循環系統醫學中，灌注系統對於冠狀動脈繞道手術和瓣膜置換術至關重要。在移植醫學中，灌注系統維持並提高腎臟、肝臟和心臟等器官的活力，從而確保移植成功並減少等待時間。在腫瘤學中，灌注系統用於隔離肢體灌注技術，將高劑量的化療輸送到特定部位並最大限度地減少全身副作用。此外，在重症加護中，體外膜氧氣療法(ECMO) 是灌注技術的一種救生應用，為患有嚴重心臟和肺部疾病的患者提供延長的心臟和呼吸支持。灌注系統的多功能性和有效性在改善這些不同應用的治療和患者預後方面發揮關鍵作用。

哪些因素推動了灌注系統市場的成長？

灌注系統市場的成長受到多種因素的推動。主要促進因素之一是心血管疾病的日益增加以及對心血管手術和介入的需求不斷增加。全球人口老化也促進了市場擴張，因為老年人更有可能需要依賴灌注系統的手術。更複雜的可攜式灌注設備等技術進步透過擴大應用範圍和改善患者預後，進一步推動了市場成長。此外，對器官移植的日益重視和器官保存技術的不斷改進正在推動對灌注系統的需求。灌注系統在腫瘤學和再生醫學等新興領域的日益廣泛使用也是一個主要的成長動力。隨著醫療保健提供者尋求改善治療結果和患者照護，對先進灌注系統的需求正在上升，預計這將在未來幾年推動強勁的市場成長。

部分

應用（心肺灌注系統、細胞灌注系統、離體器官灌注系統）

受訪公司範例

  • ALA Scientific Instruments, Inc.
  • Getinge AB
  • Harvard Bioscience, Inc.
  • Lifeline Scientific, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Merck KgaA
  • Nipro Corporation
  • Repligen Corporation
  • Spectrum Laboratories, Inc.
  • Terumo Corporation
  • Xenios AG
  • XVIVO Perfusion AB

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 並未遵循典型的 LLM 或特定產業的 SLM查詢，而是建立了一個從全球專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP13918

Global Perfusion Systems Market to Reach US$1.6 Billion by 2030

The global market for Perfusion Systems estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Cardiopulmonary Perfusion Systems, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$671.0 Million by the end of the analysis period. Growth in the Cell Perfusion Systems segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$336.0 Million While China is Forecast to Grow at 4.1% CAGR

The Perfusion Systems market in the U.S. is estimated at US$336.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$254.9 Million by the year 2030 trailing a CAGR of 4.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Perfusion Systems Market - Key Trends and Drivers Summarized

How Do Perfusion Systems Revolutionize Medical Procedures?

Perfusion systems play a crucial role in modern medical procedures by ensuring the effective delivery of oxygen and essential nutrients to tissues and organs during surgeries and other critical medical interventions. These systems are indispensable in cardiopulmonary bypass surgeries, organ transplantation, and various forms of intensive care. During open-heart surgery, for example, perfusion systems temporarily take over the function of the heart and lungs, maintaining blood circulation and oxygenation. This capability is vital for the success of complex surgical procedures and has significantly improved patient outcomes. Moreover, in organ transplantation, perfusion systems are used to preserve organs outside the body, extending the time available for transplantation and improving the viability of donor organs. The precision and reliability of perfusion systems have revolutionized the field of surgery and critical care, enabling more complex and life-saving procedures to be performed safely.

What Technological Innovations Are Shaping Perfusion Systems?

Technological innovations are at the forefront of advancements in perfusion systems, enhancing their efficiency, safety, and functionality. One notable development is the integration of advanced monitoring and control technologies, which allow for real-time assessment and adjustment of perfusion parameters. This ensures optimal perfusion conditions and reduces the risk of complications. Another significant innovation is the use of biocompatible materials and coatings in the construction of perfusion devices, which minimizes the risk of adverse reactions and enhances patient safety. Additionally, the advent of portable and minimally invasive perfusion systems has expanded their use beyond the operating room to include field hospitals and emergency settings. Advances in software and data analytics also enable more precise control and monitoring, improving outcomes in both surgical and non-surgical applications. These technological strides are making perfusion systems more versatile and effective, meeting the evolving needs of healthcare providers.

How Are Perfusion Systems Applied in Various Medical Fields?

Perfusion systems are applied across a broad spectrum of medical fields, each leveraging their capabilities to enhance patient care. In cardiovascular medicine, these systems are essential for procedures like coronary artery bypass grafting and valve replacement surgeries. In transplantation medicine, perfusion systems preserve and enhance the viability of organs such as kidneys, livers, and hearts, facilitating successful transplants and reducing waiting times. In oncology, perfusion systems are used in isolated limb perfusion techniques to deliver high doses of chemotherapy to specific areas, minimizing systemic side effects. Additionally, in critical care, extracorporeal membrane oxygenation (ECMO) is a life-saving application of perfusion technology, providing prolonged cardiac and respiratory support to patients with severe heart and lung conditions. The versatility and effectiveness of perfusion systems in these varied applications underscore their vital role in advancing medical treatment and patient outcomes.

What Factors Are Driving the Growth in the Perfusion Systems Market?

The growth in the perfusion systems market is driven by several factors. One of the primary drivers is the increasing prevalence of cardiovascular diseases and the rising demand for cardiac surgeries and interventions. The aging global population is also contributing to the market expansion, as older individuals are more likely to require surgeries that depend on perfusion systems. Technological advancements, such as the development of more sophisticated and portable perfusion devices, are further propelling market growth by expanding the range of applications and improving patient outcomes. Additionally, the growing emphasis on organ transplantation and the continuous improvement in organ preservation techniques are boosting the demand for perfusion systems. The expanding use of perfusion systems in emerging fields such as oncology and regenerative medicine is also a significant growth driver. As healthcare providers seek to enhance treatment efficacy and patient care, the demand for advanced perfusion systems is set to increase, ensuring robust market growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Perfusion Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Cardiopulmonary Perfusion Systems, Cell Perfusion Systems, EX Vivo Organ Perfusion System)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • ALA Scientific Instruments, Inc.
  • Getinge AB
  • Harvard Bioscience, Inc.
  • Lifeline Scientific, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Merck KgaA
  • Nipro Corporation
  • Repligen Corporation
  • Spectrum Laboratories, Inc.
  • Terumo Corporation
  • Xenios AG
  • XVIVO Perfusion AB

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Perfusion Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Organ Preservation Technologies Propel Growth in Perfusion Systems Market
    • Increasing Demand for Minimally Invasive Surgical Procedures Strengthens Business Case for Perfusion Systems
    • Technological Innovations in Perfusion Pumps Accelerate Market Adoption
    • Rising Prevalence of Cardiovascular Diseases Spurs Demand for Perfusion Systems
    • Expansion of Organ Transplantation Procedures Generates Market Opportunities
    • Growing Investments in Healthcare Infrastructure Sustain Market Growth
    • Adoption of Portable and Compact Perfusion Systems Expands Addressable Market
    • Increasing Focus on Patient Safety and Outcome Improves Demand for Advanced Perfusion Systems
    • Regulatory Approvals and Compliance Requirements Propel Market Growth
    • Development of Smart Perfusion Systems with Real-Time Monitoring Throws Spotlight on Technological Advancements
    • Rising Geriatric Population Drives Demand for Cardiac Perfusion Systems
    • Increasing Number of Critical Care Units Drives Adoption of Perfusion Systems
    • Strategic Collaborations and Partnerships in Healthcare Sector Strengthen Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiopulmonary Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cardiopulmonary Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Cardiopulmonary Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cell Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Cell Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Cell Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Perfusion Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for EX Vivo Organ Perfusion System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for EX Vivo Organ Perfusion System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for EX Vivo Organ Perfusion System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • JAPAN
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • CHINA
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • EUROPE
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Perfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Perfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • FRANCE
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • GERMANY
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Rest of Europe 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Asia-Pacific 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of World 15-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion Systems, Cell Perfusion Systems and EX Vivo Organ Perfusion System for the Years 2015, 2025 & 2030

IV. COMPETITION